848
+0.36%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Muromachi Chemicals
Its shares trade on Tokyo Stock Exchange under the ticker 4885.T. It has been listed since 26 February 2021. In the fiscal year to 31 May 2026, it reported revenue of ¥7.84bn and net income of ¥163.0m. At that date it held total assets of ¥6.35bn and shareholders' equity of ¥2.58bn.
Muromachi Chemicals, Inc. engages in the manufacture and sale of pharmaceutical products and health food. The company is headquartered in Omuta-Shi, Fukuoka-Ken. The company went IPO on 2021-02-26. The firm operates through three segments. The Pharmaceutical segment is mainly engaged in the manufacture, sale, import and export of drug substances such as calcium polystyrene sulfonate, potassium warfarin, histamine dihydrochloride and others. The Health Food segment is mainly engaged in the manufacture and sale of health food products such as stick-type jelly and T-pouch-type jelly products. The Chemicals segment is mainly engaged in the recycle processing of ion exchange resins, the manufacture and sale of separation membranes and pure water production equipment, as well as the manufacture, processing and sale of functional adhesives and electronic component materials.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 26 Feb 2021
- Employees
- 205
- Website
- muro-chem.co.jp ↗
Leadership
Pay as last reported
- Junichi AokiPresident & Representative Director, since 2010
- Hidenori HattoriDirector & Vice President, since 2012
- Satoshi IuchiDirector & General Manager-Administration, since 2007
- Hirotoshi InokuchiDirector & Manager-Functional Materials Sales, since 2010
- Tomoki TanakaAuditor, since 1979
- Tetsuro MurayamaChairman, since 1983
- Hidenori HattoriDirector & Vice President, since 2013
- Junichi AokiPresident & Representative Director, since 2015
- Satoshi IuchiDirector & General Manager-Administration, since 2018
- Hiroomi YamamotoIndependent Outside Director, since 2019
- Kazuhito TakamiyaManaging Director, since 2017
- Hirotoshi InokuchiDirector & Manager-Functional Materials Sales, since 2019
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Muromachi Chemicals manufactures drug substances like calcium polystyrene sulfonate for the Pharmaceutical segment.
- The Health Food segment sells stick-type jelly and T-pouch-type jelly products to consumers.
- The Chemicals segment recycles ion exchange resins and produces separation membranes for industrial use.
Weaknesses
- The company employs only 205 full-time staff members across its three business segments.
- Muromachi Chemicals operates from Omuta-shi, which may limit access to broader talent pools.
- The firm went public on 26 February 2021, indicating a relatively short market history.
Opportunities
- Expanding the sale of functional adhesives and electronic component materials in the Chemicals segment.
- Increasing import and export activities for drug substances within the Pharmaceutical segment globally.
- Growing demand for pure water production equipment and separation membranes in industrial applications.
Threats
- Fluctuations in the supply of raw materials for manufacturing drug substances and health foods.
- Intense competition in the health food market for stick-type jelly and T-pouch-type products.
- Regulatory changes affecting the manufacture and sale of pharmaceutical products in Japan.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.